18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria
- Author
- Julie Bolcaen (UGent) , Marjan Acou (UGent) , Tom Boterberg (UGent) , Christian Vanhove (UGent) , Filip De Vos (UGent) , Caroline Van den Broecke (UGent) , Roel Van Holen (UGent) , Karel Deblaere (UGent) and Ingeborg Goethals (UGent)
- Organization
- Keywords
- fluorine-18 fluoromethylcholine, glioblastoma, MRI, PET, therapy response, POSITRON-EMISSION-TOMOGRAPHY, NEWLY-DIAGNOSED GLIOBLASTOMA, RECURRENT MALIGNANT GLIOMA, HIGH-GRADE GLIOMAS, PROSTATE-CANCER, O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET, DELAYED INTERVALS, TUMOR, BEVACIZUMAB, MULTIFORME
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 277.90 KB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8502500
- MLA
- Bolcaen, Julie, et al. “18F-FCho PET and MRI for the Prediction of Response in Glioblastoma Patients According to the RANO Criteria.” NUCLEAR MEDICINE COMMUNICATIONS, vol. 38, no. 3, 2017, pp. 242–49, doi:10.1097/mnm.0000000000000638.
- APA
- Bolcaen, J., Acou, M., Boterberg, T., Vanhove, C., De Vos, F., Van den Broecke, C., … Goethals, I. (2017). 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria. NUCLEAR MEDICINE COMMUNICATIONS, 38(3), 242–249. https://doi.org/10.1097/mnm.0000000000000638
- Chicago author-date
- Bolcaen, Julie, Marjan Acou, Tom Boterberg, Christian Vanhove, Filip De Vos, Caroline Van den Broecke, Roel Van Holen, Karel Deblaere, and Ingeborg Goethals. 2017. “18F-FCho PET and MRI for the Prediction of Response in Glioblastoma Patients According to the RANO Criteria.” NUCLEAR MEDICINE COMMUNICATIONS 38 (3): 242–49. https://doi.org/10.1097/mnm.0000000000000638.
- Chicago author-date (all authors)
- Bolcaen, Julie, Marjan Acou, Tom Boterberg, Christian Vanhove, Filip De Vos, Caroline Van den Broecke, Roel Van Holen, Karel Deblaere, and Ingeborg Goethals. 2017. “18F-FCho PET and MRI for the Prediction of Response in Glioblastoma Patients According to the RANO Criteria.” NUCLEAR MEDICINE COMMUNICATIONS 38 (3): 242–249. doi:10.1097/mnm.0000000000000638.
- Vancouver
- 1.Bolcaen J, Acou M, Boterberg T, Vanhove C, De Vos F, Van den Broecke C, et al. 18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria. NUCLEAR MEDICINE COMMUNICATIONS. 2017;38(3):242–9.
- IEEE
- [1]J. Bolcaen et al., “18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria,” NUCLEAR MEDICINE COMMUNICATIONS, vol. 38, no. 3, pp. 242–249, 2017.
@article{8502500, author = {{Bolcaen, Julie and Acou, Marjan and Boterberg, Tom and Vanhove, Christian and De Vos, Filip and Van den Broecke, Caroline and Van Holen, Roel and Deblaere, Karel and Goethals, Ingeborg}}, issn = {{0143-3636}}, journal = {{NUCLEAR MEDICINE COMMUNICATIONS}}, keywords = {{fluorine-18 fluoromethylcholine,glioblastoma,MRI,PET,therapy response,POSITRON-EMISSION-TOMOGRAPHY,NEWLY-DIAGNOSED GLIOBLASTOMA,RECURRENT MALIGNANT GLIOMA,HIGH-GRADE GLIOMAS,PROSTATE-CANCER,O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET,DELAYED INTERVALS,TUMOR,BEVACIZUMAB,MULTIFORME}}, language = {{eng}}, number = {{3}}, pages = {{242--249}}, title = {{18F-FCho PET and MRI for the prediction of response in glioblastoma patients according to the RANO criteria}}, url = {{http://doi.org/10.1097/mnm.0000000000000638}}, volume = {{38}}, year = {{2017}}, }
- Altmetric
- View in Altmetric
- Web of Science
- Times cited: